 These "targets" should generally be as unlike any proteins or parts of proteins in humans as possible, to reduce the likelihood of side effects.The targets should also be common across many strains of a virus, or even among different species of virus in the same family, so a single drug will have broad effectiveness.For example, a researcher might target a critical enzyme synthesized by the virus, but not by the patient, that is common across strains, and see what can be done to interfere with its operation.